1351 |
Sputum Smear Microscopy: Use of Quality Control Slide- QCP and QCN |
09/04/2022 |
|
1353 |
EQA for Fluorescent Microscopy [FM] |
09/04/2022 |
|
1355 |
System Check Control [SCC] of GeneXpert Technology |
09/04/2022 |
|
1356 |
Sample Processing Control [SPC] of GeneXpert Technology |
09/04/2022 |
|
1357 |
Probe Check Control [PCC] of GeneXpert Technology |
09/04/2022 |
|
1358 |
Molecular Beacon Technology for GeneXpert MTB-RIF Assay |
09/04/2022 |
|
1359 |
WHO Recommended SOPs for Xpert MTB/RIF Sample Processing |
09/04/2022 |
|
1362 |
Smear Microscopic Examination: Adding Immersion Oil to the Slide |
09/04/2022 |
|
490 |
Nucleic Acid Amplification Tests [NAAT] |
09/04/2022 |
|
70 |
Specimen Transport |
09/04/2022 |
|
1370 |
Culture Conversion |
09/04/2022 |
|
1373 |
NAAT Instrument Monthly Data Archive and Data Back-up |
09/04/2022 |
|
1374 |
LPA Biosafety Essentials: Waste Disposal |
09/04/2022 |
|
1375 |
Specimen Preparation for LC and LPA Labs |
09/04/2022 |
|
1378 |
Ideal Infrastructure Required for Microscopy Centers |
09/04/2022 |
|
1381 |
Prevention of Some Common Issues Encountered During Smear Microscopy at the DMC |
09/04/2022 |
|
1391 |
Safety Precautions to be Followed in TB Laboratory Setting |
09/04/2022 |
|
1394 |
Sputum Smear Microscopy: Recording Results for Reagent Validation at the TB Laboratory |
09/04/2022 |
|
1397 |
External Quality Assurance [EQA] for Microscopy |
09/04/2022 |
|
1418 |
Molecular Mechanism of Multi-drug Resistance in Mycobacterium tuberculosis |
09/04/2022 |
|
1424 |
Flow Chart of M/XDR-TB Patients on Longer Oral Regimen from Diagnosis to Treatment Outcome |
09/04/2022 |
|
1426 |
Key Points of Health Education and Counselling in DR-TB Care |
09/04/2022 |
|
1550 |
Management of DR-TB ADR: Metallic Taste |
11/04/2022 |
|
1556 |
Understanding Key elements of Molecular Biology |
11/04/2022 |
|
1561 |
Molecular Basis of Genetic Code and Mutation |
11/04/2022 |
|
1416 |
Molecular Basis: Introduction to Polymerase Chain Reaction(PCR) Technology |
11/04/2022 |
|
1558 |
Structure of DNA in a Prokaryotic Cell |
11/04/2022 |
|
1566 |
Explanation of Treatment of Non-tuberculous Mycobacteria [NTM] |
11/04/2022 |
|
1570 |
Use of Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen in Patients with Renal Impairment |
11/04/2022 |
|
1580 |
Socio economic factors affecting TB patients |
14/04/2022 |
|